Insight

BAX protein’s role in cell death, a promising target for cancer therapy – Dana-Farber Cancer Institute

Photo taken from Dana-Farber Cancer Institute/LinkedIn

Jul 6, 2024, 14:44

BAX protein’s role in cell death, a promising target for cancer therapy – Dana-Farber Cancer Institute

Dana-Farber Cancer Institute shared a post on LinkedIn:

“For years, researchers have explored BAX protein’s role in cell death, a promising target for cancer therapy. New findings by Dana-Farber offer a starting point for drugs that inhibit BAX through a covalent mechanism.

‘BAX has been a focus of my lab for nearly 20 years,’ says Loren Walensky, MD, PhD, who began studying the protein as a postdoctoral fellow in the early 2000s. ‘Its enormous potential as a therapeutic target – if you activate it, you can cause malignant cells to die; if you shut it down, you can prevent healthy cells from dying – led us to explore its mechanism of activation and de-activation.’

Learn more here.”

Source: Dana-Farber Cancer Institute/LinkedIn

BAX protein cancer Cancer research cancer therapy cell death covalent inhibition Dana-Farber Cancer Institute drug development Loren Walensky MD PhD molecular biology OncoDaily Oncology therapeutic target

China Anti-Cancer Association (CACA) and OncoDaily Announce Strategic Partnership to Advance Global Cancer Care

Donald Trump: Thrilled to announce Robert F. Kennedy Jr. as The United States Secretary of HHS

Overview of ASCO Breakthrough

Robert De Niro and Prostate Cancer: How He Went Against, How He Survived, and More

Isabel Mestres: In a world where the fight against cancer knows no borders, collaboration is not optional - it’s essential

Special Coverage